Skip to content

Study Comparing Tutomesh® Repair to Conventional Surgical Techniques in Potentially Contaminated Hernia Repair and Abdominal Wall Reconstruction

Multicentric Prospective Randomized Study Comparing Technique of Tension-free Repair With Placement of a Bovine Pericardium Bioprosthesis (Tutopatch® and Tutomesh®) to Current Conventional Surgical Techniques in Potentially Contaminated Hernia Repair and Abdominal Wall Reconstruction

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01073072
Acronym
Tutomesh
Enrollment
134
Registered
2010-02-23
Start date
2009-01-31
Completion date
2011-10-31
Last updated
2012-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Potentially Contaminated Hernia Repair, Potentially Contaminated Abdominal Wall Reconstruction

Keywords

bovine pericardium bioprosthesis, contamination, hernia repair, abdominal wall reconstruction, Tutomesh, Tutopatch, Potentially Contaminated Hernia Repair, Potentially Contaminated Abdominal Wall Reconstruction

Brief summary

This is a multicentric prospective randomized study comparing technique of tension-free repair with placement of a bovine pericardium bioprosthesis (Tutopatch® and Tutomesh®) to current conventional surgical techniques in potentially contaminated hernia repair and abdominal wall reconstruction. The hypothesis is that using Tutomesh® prostheses reduces the risk of postoperative complications at 30 days in the treatment of incisional hernias or complicated abdominal wall hernias (ref early complications) for potentially contaminated fields.

Interventions

Conventional technique to repair potentially contaminated incisional or abdominal wall hernias

PROCEDURETechnique Tutomesh®

Technique of abdominal wall reconstruction or hernia repair strengthened by Tutomesh® in potentially contaminated environment.

Sponsors

Centre Hospitalier Régional Universitaire Montpellier
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient presenting with an incisional hernia or complicated hernia contraindicating the use of non absorbable mesh: * Infected incisional hernia: abdominal wall abscess, chronic fistula * Incisional hernia with high septic potential: incisional hernia with strangulation of one or more intestinal loops, repair of incisional hernia during surgery requiring opening of the digestive tube (digestive resection, restoration of digestive continuity, gastro-intestinal perforation, peritonitis from digestive origin) * Recurrent incisional hernia with problem of cutaneous healing * Incisional hernia requiring important intestinal adhesiolysis * Patients signing informed consent form after reading and understanding the information letter \_ Patients are more than 18 year old

Exclusion criteria

* Patient with major anesthetic risk (ASA 4) * Patient suffering from immunodepression or under immunosuppressor treatment (corticoids…) * Patients already enrolled in another study * Patient suffering from severe disease not allowing a 1-year follow-up * Patient refusing to be enrolled after consulting the information letter * Patient presenting with a too large incisional hernia, superior to 140x200 mm * Pregnancy

Design outcomes

Primary

MeasureTime frame
risk of postoperative complications: occurrence of complications related to pathology or surgery will be evaluated with the report of adverse events and emergency visits30 days

Secondary

MeasureTime frame
recurrence risk: Assessment of relapse thanks to emergency visits and to adverse events' report1 year
the impact on postoperative pain: Assessment of postoperative pain by postponing analgesics1 year
the socio-economic impact will be evaluated with the concomitant treatment and hospitalisations.1 year
the impact on patients' quality of life: The evaluation of patient's quality of life will be done with the questionnaire quality of life SF121 year

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026